magnifying glass
logo for INmune Bio

INmune Bio

Business Services · Florida, United States · <25 Employees

Get Full Access

Who is INmune Bio

INmuneBio,Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms that are both in clinical trials. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and mechanistic target of many diseases. DN-TNF is in clinical trial to determine if it can treat cancer (INB03™), Mild Alzheimer's disease, Mild Cognitive Impairment and treatment resistant depression (XPro). The Natural Killer Cell Priming Platform includes INKmune™ aimed at priming the patient's NK cells to eliminate minimal residual disease in patients with cancer. INmune Bio's product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation.Read More

Headquarters

Headquarters:

225 NE Mizner Blvd, Suite 640, Boca Raton, Florida, 33432, United States
Revenue

Revenue:

<$5 Million
Stock Symbol

Stock Symbol:

INMB
INmune Bio's Social Media
SIC Code 28,283
NAICS Code 3254,541714
Ticker NASDAQ: INMB
Popular Searches:

INmune Bio Inc

Inmune Bio , Inc.

INmune Bio Inc.

INmune Bio

INmune Bio, Inc.

Top Competitors of INmune Bio

Employess
148
revenue
$31 Million

1

Employess
<25
revenue
$14 Million

2

Employess
<25
revenue
<$5 Million

3

Employess
<25
revenue
<$5 Million

4

Employess
29
revenue
$11 Million

5

Employess
<25
revenue
$6 Million

6

INmune Bio's Org Chart

PhonePhoneEmailEmail
Cory Ellspermann
Cory Ellspermann

Controller & Vice President, Financ...

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

INmune Bio's Tech Stack

ASP.NET

By

Microsoft

Google Website Translator

By

Google

Font Awesome

By

Font Awesome

GTranslate

By

2GLux
See more technologies

INmune Bio News & Media

USPTO Issues Patent Covering Use of XPro™ for Treatment of CNS Diseases

Boca Raton, Florida, June 22, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announces the issuance of U.S. Pat. No. 11,365,229 for “METHODS OF TREATING NEUROLOGICAL DISEASES,” a patent directed to use of Dominant Negative Tumor Necrosis Factor (DN-TNF) variants, such as the Company’s XPro™, by peripheral administration for crossing the

INmune Bio, Inc. Presents Data on Combination Therapy with INB03™ on Overcoming Resistance to HER2 Targeted Therapies in Breast Cancer

In pre-clinical models of trastuzumab resistant MUC4 HER2+ breast cancer, treatment with INB03™ decreases MUC4 expression, reverses resistance to trastuzumab based therapies, and promotes an immunologically active TME.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INmune Bio, Inc. - INMB

New York, New York--(Newsfile Corp. - June 15, 2022) - Pomerantz LLP is investigating claims on behalf of investors of INmune Bio, Inc. ("INmune" or the "Company") (NASDAQ: INMB). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether INmune and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...
Subscribe to "INmune Bio" News

Frequently Asked Questions regarding INmune Bio

Where are INmune Bio’s headquarters?

INmune Bio’s headquarters are in 225 NE Mizner Blvd, Suite 640, Boca Raton, Florida, 33432, United States

What is INmune Bio’s stock symbol?

INmune Bio’s stock symbol is INMB

What is INmune Bio’s official website?

INmune Bio’s official website is www.inmunebio.com

What is INmune Bio’s Revenue?

INmune Bio’s revenue is <$5 Million

What is INmune Bio’s SIC code?

INmune Bio’s SIC: 28,283

What is INmune Bio’s NAICS code?

INmune Bio’s NAICS: 3254,541714

How many employees are working in INmune Bio?

INmune Bio has <25 employees

What is INmune Bio’s industry?

INmune Bio is in the industry of: Business Services, Research & Development, Manufacturing

Who are INmune Bio’s main competitors?

INmune Bio's main competitors are: Nantkwest, Checkmate Pharmaceuticals, Targovax, Leap Therapeutics

What is INmune Bio's tech stack?

The technologies that are used by INmune Bio are: ASP.NET, Google Website Translator, Font Awesome, GTranslate

See more information about INmune Bio
4.4/5 on G2 Crowd